Methylene blue@silver nanoprisms conjugates as a strategy against Candida albicans isolated from balanoposthitis using photodynamic inactivation

•Silver prismatic nanoplatelets (AgNPRs) with dimensions 37 ± 8 nm were prepared and characterized.•Different concentrations of methylene blue (MB) were conjugated to AgNPRs and monitored with zeta potential and optical analysis.•MB (at 100 µmol⋅L−1) decreased C. albicans 1 log10 after 4 min light i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Photodiagnosis and photodynamic therapy 2024-04, Vol.46, p.104066-104066, Article 104066
Hauptverfasser: Rodrigues, Cláudio H., Silva, Bruna Pereira, Silva, Marques L.R., Gouveia, Dimitri C., Fontes, Adriana, Macêdo, Danielle P.C., Santos, Beate S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 104066
container_issue
container_start_page 104066
container_title Photodiagnosis and photodynamic therapy
container_volume 46
creator Rodrigues, Cláudio H.
Silva, Bruna Pereira
Silva, Marques L.R.
Gouveia, Dimitri C.
Fontes, Adriana
Macêdo, Danielle P.C.
Santos, Beate S.
description •Silver prismatic nanoplatelets (AgNPRs) with dimensions 37 ± 8 nm were prepared and characterized.•Different concentrations of methylene blue (MB) were conjugated to AgNPRs and monitored with zeta potential and optical analysis.•MB (at 100 µmol⋅L−1) decreased C. albicans 1 log10 after 4 min light irradiation.•MBAgNPrs (MB = 100 µmol⋅L−1) completely inactivated Candida albicans isolated from balanoposthitis at 2 min of light irradiation.•We suggest that AgNPRs enhanced MB photoaction via plasmonic effect as well as by reducing MB dimerization process. Balanoposthitis can affect men in immunocompromised situations, such as HIV infection and diabetes. The main associated microorganism is Candida albicans, which can cause local lesions, such as the development of skin cracks associated with itching. As an alternative to conventional treatment, there is a growing interest in the photodynamic inactivation (PDI). It has been shown that the association of photosensitizers with metallic nanoparticles may improve the effectiveness of PDI via plasmonic effect. We have recently shown that the association of methylene blue (MB), a very known photosensitizer, with silver prismatic nanoplatelets (AgNPrs) improved PDI of a resistant strain of Staphylococcus aureus. To further investigate the experimental conditions involved in PDI improvement, in the present study, we studied the effect of MB concentration associated with AgNPrs exploring spectral analysis, zeta potential measurements, and biological assays, testing the conjugated system against C. albicans isolated from a resistant strain of balanoposthitis. The AgNPrs were synthesized through silver anisotropic seed growth induced by the anionic stabilizing agent poly(sodium 4-styrenesulfonate) and showed a plasmon band fully overlapping the MB absorption band. MB and AgNPrs were conjugated through electrostatic association and three different MB concentrations were tested in the nanosystems. Inactivation using red LED light (660 nm) showed a dose dependency in respect to the MB concentration in the conjugates. Using the highest MB concentration (100 µmol⋅L−1) with AgNPr, it was possible to completely inactivate the microorganisms upon a 2 min irradiation exposure. Analyzing optical changes in the conjugates we suggest that these results indicate that AgNPrs are enhancers of MB photodynamic action probably by a combined mechanism of plasmonic effect and reduction of MB dimerization. Therefore, MBAgNPrs can be considere
doi_str_mv 10.1016/j.pdpdt.2024.104066
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3022569984</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1572100024001054</els_id><sourcerecordid>3022569984</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-9a1cdb65c3385e134f7b17de04239cce0721c60299d66383c7e1e6ae3f88012a3</originalsourceid><addsrcrecordid>eNp9kV2L1DAUhou4uOvqLxAkl950zFfT9kJQBleFFW_0OqTJ6UyGNqk56cD8i_3JZnZWL4VAcsJz3vPxVtUbRjeMMvX-sFnc4vKGUy7Lj6RKPatuWNeKmjV9-7y8m5bXjFJ6Xb1EPFAqZE_li-padE3DOyZvqofvkPenCQKQYVrhI_rpCIkEE-KSPM5IbAyHdWcyIDHlEMypBLsTMTvjA2ayNcF5Z4iZBm9NQOIxTgVxZExxJoOZzmIR895nj2RFH3Zk2ccc3SmY2Vvig7HZH032MbyqrkYzIbx-um-rX3eff26_1vc_vnzbfrqvrWhkrnvDrBtUY0WZBZiQYzuw1gGVXPTWAm05s4ryvndKiU7YFhgoA2LsOsq4EbfVu4vukuLvFTDr2aOFqTQLcUUtKOeN6vtOFlRcUJsiYoJRl9XMJp00o_pshT7oRyv02Qp9saJkvX0qsA4zuH85f3dfgA8XAMqYRw9Jo_UQLDifwGbtov9vgT_7eJ8z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3022569984</pqid></control><display><type>article</type><title>Methylene blue@silver nanoprisms conjugates as a strategy against Candida albicans isolated from balanoposthitis using photodynamic inactivation</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elsevier ScienceDirect Journals</source><creator>Rodrigues, Cláudio H. ; Silva, Bruna Pereira ; Silva, Marques L.R. ; Gouveia, Dimitri C. ; Fontes, Adriana ; Macêdo, Danielle P.C. ; Santos, Beate S.</creator><creatorcontrib>Rodrigues, Cláudio H. ; Silva, Bruna Pereira ; Silva, Marques L.R. ; Gouveia, Dimitri C. ; Fontes, Adriana ; Macêdo, Danielle P.C. ; Santos, Beate S.</creatorcontrib><description>•Silver prismatic nanoplatelets (AgNPRs) with dimensions 37 ± 8 nm were prepared and characterized.•Different concentrations of methylene blue (MB) were conjugated to AgNPRs and monitored with zeta potential and optical analysis.•MB (at 100 µmol⋅L−1) decreased C. albicans 1 log10 after 4 min light irradiation.•MBAgNPrs (MB = 100 µmol⋅L−1) completely inactivated Candida albicans isolated from balanoposthitis at 2 min of light irradiation.•We suggest that AgNPRs enhanced MB photoaction via plasmonic effect as well as by reducing MB dimerization process. Balanoposthitis can affect men in immunocompromised situations, such as HIV infection and diabetes. The main associated microorganism is Candida albicans, which can cause local lesions, such as the development of skin cracks associated with itching. As an alternative to conventional treatment, there is a growing interest in the photodynamic inactivation (PDI). It has been shown that the association of photosensitizers with metallic nanoparticles may improve the effectiveness of PDI via plasmonic effect. We have recently shown that the association of methylene blue (MB), a very known photosensitizer, with silver prismatic nanoplatelets (AgNPrs) improved PDI of a resistant strain of Staphylococcus aureus. To further investigate the experimental conditions involved in PDI improvement, in the present study, we studied the effect of MB concentration associated with AgNPrs exploring spectral analysis, zeta potential measurements, and biological assays, testing the conjugated system against C. albicans isolated from a resistant strain of balanoposthitis. The AgNPrs were synthesized through silver anisotropic seed growth induced by the anionic stabilizing agent poly(sodium 4-styrenesulfonate) and showed a plasmon band fully overlapping the MB absorption band. MB and AgNPrs were conjugated through electrostatic association and three different MB concentrations were tested in the nanosystems. Inactivation using red LED light (660 nm) showed a dose dependency in respect to the MB concentration in the conjugates. Using the highest MB concentration (100 µmol⋅L−1) with AgNPr, it was possible to completely inactivate the microorganisms upon a 2 min irradiation exposure. Analyzing optical changes in the conjugates we suggest that these results indicate that AgNPrs are enhancers of MB photodynamic action probably by a combined mechanism of plasmonic effect and reduction of MB dimerization. Therefore, MBAgNPrs can be considered a suitable choice to be applied in PDI of resistant microorganisms.</description><identifier>ISSN: 1572-1000</identifier><identifier>EISSN: 1873-1597</identifier><identifier>DOI: 10.1016/j.pdpdt.2024.104066</identifier><identifier>PMID: 38552814</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Balanitis - drug therapy ; Balanitis - microbiology ; Candida albicans - drug effects ; Dimerization ; Humans ; Metal Nanoparticles - chemistry ; Metal Nanoparticles - therapeutic use ; Methylene Blue - pharmacology ; Photochemotherapy - methods ; Photodynamic Therapy ; Photosensitizing Agents - pharmacology ; Plasmonic effect ; Silver - pharmacology ; Silver nanoparticles ; Yeast infection</subject><ispartof>Photodiagnosis and photodynamic therapy, 2024-04, Vol.46, p.104066-104066, Article 104066</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c354t-9a1cdb65c3385e134f7b17de04239cce0721c60299d66383c7e1e6ae3f88012a3</cites><orcidid>0000-0002-9909-5462</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1572100024001054$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,860,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38552814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodrigues, Cláudio H.</creatorcontrib><creatorcontrib>Silva, Bruna Pereira</creatorcontrib><creatorcontrib>Silva, Marques L.R.</creatorcontrib><creatorcontrib>Gouveia, Dimitri C.</creatorcontrib><creatorcontrib>Fontes, Adriana</creatorcontrib><creatorcontrib>Macêdo, Danielle P.C.</creatorcontrib><creatorcontrib>Santos, Beate S.</creatorcontrib><title>Methylene blue@silver nanoprisms conjugates as a strategy against Candida albicans isolated from balanoposthitis using photodynamic inactivation</title><title>Photodiagnosis and photodynamic therapy</title><addtitle>Photodiagnosis Photodyn Ther</addtitle><description>•Silver prismatic nanoplatelets (AgNPRs) with dimensions 37 ± 8 nm were prepared and characterized.•Different concentrations of methylene blue (MB) were conjugated to AgNPRs and monitored with zeta potential and optical analysis.•MB (at 100 µmol⋅L−1) decreased C. albicans 1 log10 after 4 min light irradiation.•MBAgNPrs (MB = 100 µmol⋅L−1) completely inactivated Candida albicans isolated from balanoposthitis at 2 min of light irradiation.•We suggest that AgNPRs enhanced MB photoaction via plasmonic effect as well as by reducing MB dimerization process. Balanoposthitis can affect men in immunocompromised situations, such as HIV infection and diabetes. The main associated microorganism is Candida albicans, which can cause local lesions, such as the development of skin cracks associated with itching. As an alternative to conventional treatment, there is a growing interest in the photodynamic inactivation (PDI). It has been shown that the association of photosensitizers with metallic nanoparticles may improve the effectiveness of PDI via plasmonic effect. We have recently shown that the association of methylene blue (MB), a very known photosensitizer, with silver prismatic nanoplatelets (AgNPrs) improved PDI of a resistant strain of Staphylococcus aureus. To further investigate the experimental conditions involved in PDI improvement, in the present study, we studied the effect of MB concentration associated with AgNPrs exploring spectral analysis, zeta potential measurements, and biological assays, testing the conjugated system against C. albicans isolated from a resistant strain of balanoposthitis. The AgNPrs were synthesized through silver anisotropic seed growth induced by the anionic stabilizing agent poly(sodium 4-styrenesulfonate) and showed a plasmon band fully overlapping the MB absorption band. MB and AgNPrs were conjugated through electrostatic association and three different MB concentrations were tested in the nanosystems. Inactivation using red LED light (660 nm) showed a dose dependency in respect to the MB concentration in the conjugates. Using the highest MB concentration (100 µmol⋅L−1) with AgNPr, it was possible to completely inactivate the microorganisms upon a 2 min irradiation exposure. Analyzing optical changes in the conjugates we suggest that these results indicate that AgNPrs are enhancers of MB photodynamic action probably by a combined mechanism of plasmonic effect and reduction of MB dimerization. Therefore, MBAgNPrs can be considered a suitable choice to be applied in PDI of resistant microorganisms.</description><subject>Balanitis - drug therapy</subject><subject>Balanitis - microbiology</subject><subject>Candida albicans - drug effects</subject><subject>Dimerization</subject><subject>Humans</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Metal Nanoparticles - therapeutic use</subject><subject>Methylene Blue - pharmacology</subject><subject>Photochemotherapy - methods</subject><subject>Photodynamic Therapy</subject><subject>Photosensitizing Agents - pharmacology</subject><subject>Plasmonic effect</subject><subject>Silver - pharmacology</subject><subject>Silver nanoparticles</subject><subject>Yeast infection</subject><issn>1572-1000</issn><issn>1873-1597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1DAUhou4uOvqLxAkl950zFfT9kJQBleFFW_0OqTJ6UyGNqk56cD8i_3JZnZWL4VAcsJz3vPxVtUbRjeMMvX-sFnc4vKGUy7Lj6RKPatuWNeKmjV9-7y8m5bXjFJ6Xb1EPFAqZE_li-padE3DOyZvqofvkPenCQKQYVrhI_rpCIkEE-KSPM5IbAyHdWcyIDHlEMypBLsTMTvjA2ayNcF5Z4iZBm9NQOIxTgVxZExxJoOZzmIR895nj2RFH3Zk2ccc3SmY2Vvig7HZH032MbyqrkYzIbx-um-rX3eff26_1vc_vnzbfrqvrWhkrnvDrBtUY0WZBZiQYzuw1gGVXPTWAm05s4ryvndKiU7YFhgoA2LsOsq4EbfVu4vukuLvFTDr2aOFqTQLcUUtKOeN6vtOFlRcUJsiYoJRl9XMJp00o_pshT7oRyv02Qp9saJkvX0qsA4zuH85f3dfgA8XAMqYRw9Jo_UQLDifwGbtov9vgT_7eJ8z</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Rodrigues, Cláudio H.</creator><creator>Silva, Bruna Pereira</creator><creator>Silva, Marques L.R.</creator><creator>Gouveia, Dimitri C.</creator><creator>Fontes, Adriana</creator><creator>Macêdo, Danielle P.C.</creator><creator>Santos, Beate S.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9909-5462</orcidid></search><sort><creationdate>202404</creationdate><title>Methylene blue@silver nanoprisms conjugates as a strategy against Candida albicans isolated from balanoposthitis using photodynamic inactivation</title><author>Rodrigues, Cláudio H. ; Silva, Bruna Pereira ; Silva, Marques L.R. ; Gouveia, Dimitri C. ; Fontes, Adriana ; Macêdo, Danielle P.C. ; Santos, Beate S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-9a1cdb65c3385e134f7b17de04239cce0721c60299d66383c7e1e6ae3f88012a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Balanitis - drug therapy</topic><topic>Balanitis - microbiology</topic><topic>Candida albicans - drug effects</topic><topic>Dimerization</topic><topic>Humans</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Metal Nanoparticles - therapeutic use</topic><topic>Methylene Blue - pharmacology</topic><topic>Photochemotherapy - methods</topic><topic>Photodynamic Therapy</topic><topic>Photosensitizing Agents - pharmacology</topic><topic>Plasmonic effect</topic><topic>Silver - pharmacology</topic><topic>Silver nanoparticles</topic><topic>Yeast infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodrigues, Cláudio H.</creatorcontrib><creatorcontrib>Silva, Bruna Pereira</creatorcontrib><creatorcontrib>Silva, Marques L.R.</creatorcontrib><creatorcontrib>Gouveia, Dimitri C.</creatorcontrib><creatorcontrib>Fontes, Adriana</creatorcontrib><creatorcontrib>Macêdo, Danielle P.C.</creatorcontrib><creatorcontrib>Santos, Beate S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Photodiagnosis and photodynamic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodrigues, Cláudio H.</au><au>Silva, Bruna Pereira</au><au>Silva, Marques L.R.</au><au>Gouveia, Dimitri C.</au><au>Fontes, Adriana</au><au>Macêdo, Danielle P.C.</au><au>Santos, Beate S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methylene blue@silver nanoprisms conjugates as a strategy against Candida albicans isolated from balanoposthitis using photodynamic inactivation</atitle><jtitle>Photodiagnosis and photodynamic therapy</jtitle><addtitle>Photodiagnosis Photodyn Ther</addtitle><date>2024-04</date><risdate>2024</risdate><volume>46</volume><spage>104066</spage><epage>104066</epage><pages>104066-104066</pages><artnum>104066</artnum><issn>1572-1000</issn><eissn>1873-1597</eissn><abstract>•Silver prismatic nanoplatelets (AgNPRs) with dimensions 37 ± 8 nm were prepared and characterized.•Different concentrations of methylene blue (MB) were conjugated to AgNPRs and monitored with zeta potential and optical analysis.•MB (at 100 µmol⋅L−1) decreased C. albicans 1 log10 after 4 min light irradiation.•MBAgNPrs (MB = 100 µmol⋅L−1) completely inactivated Candida albicans isolated from balanoposthitis at 2 min of light irradiation.•We suggest that AgNPRs enhanced MB photoaction via plasmonic effect as well as by reducing MB dimerization process. Balanoposthitis can affect men in immunocompromised situations, such as HIV infection and diabetes. The main associated microorganism is Candida albicans, which can cause local lesions, such as the development of skin cracks associated with itching. As an alternative to conventional treatment, there is a growing interest in the photodynamic inactivation (PDI). It has been shown that the association of photosensitizers with metallic nanoparticles may improve the effectiveness of PDI via plasmonic effect. We have recently shown that the association of methylene blue (MB), a very known photosensitizer, with silver prismatic nanoplatelets (AgNPrs) improved PDI of a resistant strain of Staphylococcus aureus. To further investigate the experimental conditions involved in PDI improvement, in the present study, we studied the effect of MB concentration associated with AgNPrs exploring spectral analysis, zeta potential measurements, and biological assays, testing the conjugated system against C. albicans isolated from a resistant strain of balanoposthitis. The AgNPrs were synthesized through silver anisotropic seed growth induced by the anionic stabilizing agent poly(sodium 4-styrenesulfonate) and showed a plasmon band fully overlapping the MB absorption band. MB and AgNPrs were conjugated through electrostatic association and three different MB concentrations were tested in the nanosystems. Inactivation using red LED light (660 nm) showed a dose dependency in respect to the MB concentration in the conjugates. Using the highest MB concentration (100 µmol⋅L−1) with AgNPr, it was possible to completely inactivate the microorganisms upon a 2 min irradiation exposure. Analyzing optical changes in the conjugates we suggest that these results indicate that AgNPrs are enhancers of MB photodynamic action probably by a combined mechanism of plasmonic effect and reduction of MB dimerization. Therefore, MBAgNPrs can be considered a suitable choice to be applied in PDI of resistant microorganisms.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38552814</pmid><doi>10.1016/j.pdpdt.2024.104066</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9909-5462</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1572-1000
ispartof Photodiagnosis and photodynamic therapy, 2024-04, Vol.46, p.104066-104066, Article 104066
issn 1572-1000
1873-1597
language eng
recordid cdi_proquest_miscellaneous_3022569984
source MEDLINE; DOAJ Directory of Open Access Journals; Elsevier ScienceDirect Journals
subjects Balanitis - drug therapy
Balanitis - microbiology
Candida albicans - drug effects
Dimerization
Humans
Metal Nanoparticles - chemistry
Metal Nanoparticles - therapeutic use
Methylene Blue - pharmacology
Photochemotherapy - methods
Photodynamic Therapy
Photosensitizing Agents - pharmacology
Plasmonic effect
Silver - pharmacology
Silver nanoparticles
Yeast infection
title Methylene blue@silver nanoprisms conjugates as a strategy against Candida albicans isolated from balanoposthitis using photodynamic inactivation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T02%3A16%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methylene%20blue@silver%20nanoprisms%20conjugates%20as%20a%20strategy%20against%20Candida%20albicans%20isolated%20from%20balanoposthitis%20using%20photodynamic%20inactivation&rft.jtitle=Photodiagnosis%20and%20photodynamic%20therapy&rft.au=Rodrigues,%20Cl%C3%A1udio%20H.&rft.date=2024-04&rft.volume=46&rft.spage=104066&rft.epage=104066&rft.pages=104066-104066&rft.artnum=104066&rft.issn=1572-1000&rft.eissn=1873-1597&rft_id=info:doi/10.1016/j.pdpdt.2024.104066&rft_dat=%3Cproquest_cross%3E3022569984%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3022569984&rft_id=info:pmid/38552814&rft_els_id=S1572100024001054&rfr_iscdi=true